Postkidney transplant malignancy in egypt has a unique pattern: A three-decade experience

Transplantation

Volumn 86, Issue 8, 2008, Pages 1139-1142

  Donia, Ahmed F ^a   Mostafa, Amani ^a   Refaie, Hoda ^a   El Baz, Mahmoud ^a   Kamal, Mohamed M ^a   Ghoneim, Mohamed A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Kidney; Malignancy; Transplant

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BASAL CELL CARCINOMA; BLOOD TRANSFUSION; CANCER RECURRENCE; CHILD; CONTROLLED STUDY; EGYPT; FEMALE; FIBROSARCOMA; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SKIN CANCER; AGE; MIDDLE AGED; MORTALITY; NEOPLASM; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME;

ADOLESCENT; ADULT; AGE FACTORS; BLOOD TRANSFUSION; EGYPT; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SARCOMA, KAPOSI; TIME FACTORS;

EID: 55949125868     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318187ccb3     Document Type: Article

References (32)

1. Penn I. Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993; 7: 431.
2. Sheil AG. Patterns of malignancies following renal transplantation. Transplant Proc 1999; 31: 1263.
3. Andrés A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol 2005; 56: 71.
4. Behrend M, Kolditz M, Kliem V, et al. Malignancies in patients under long-term immunosuppression after kidney transplantation. Transplant Proc 1997; 29: 834.
5. Bakr MA, Sobh M, El-Agroudy A, et al. Study of malignancy among kidney transplant recipients. Tansplant Proc 1997; 29: 3067.
6. Wafa EW, Donia AF, Ali-Eldein B, et al. Evaluation and selection of potential live kidney donors. J Urol 2004; 171: 1424.
7. Ghoneim MA, Sobh MA, Shokeir AA, et al. Prospective randomized study of azathioprine versus cyclosporin in live-donor kidney transplantation. Am J Nephrol 1993; 13: 437.
8. Hamdy AF, El-Agroudy AE, Bakr MA, et al. Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. Am J Transplant 2005; 5: 2531.
9. Sheashaa HA, Bakr MA, Ismail AM, et al. Long-term evaluation of basiliximab induction therapy in live donor kidney transplantation: A five-year prospective randomized study. Am J Nephrol 2005; 25: 221.
10. Kamal MM, Soliman SM, Shokeir AA, et al. Bladder carcinoma among live-donor renal recipients: A single-center experience and a review of the literature. BJU Int 2008; 101: 30.
11. El-Agroudy AE, El-Baz MA, Ismail AM, et al. Clinical features and course of Kaposi's sarcoma in Egyptian kidney transplant recipients. Am J Transplant 2003; 3: 1595.
12. Moosa MR. Racial and ethnic variations in incidence and pattern of malignancies after kidney transplantation. Medicine (Baltimore) 2005; 84: 12.
13. Shmueli D,ShapiraZ, Yussim A, et al. The incidence ofKaposi sarcoma in renal transplant patients and its relation to immunosuppression. Transplant Proc 1989; 21: 3209.
14. Al-Khader AA, Suleiman M, Al-Hasani M, et al. Posttransplant Kaposi sarcoma: Staging as a guide to therapy and prognosis. Nephron 1988; 48: 165.
15. Moosa MR. Kaposi's sarcoma in kidney transplant recipients: A 23-year experience. QJM 2005; 98: 205.
16. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681.
17. Campistol JM, Gutierrez-Dalmau A, Torregrosa JV. Conversion to sirolimus: A successful treatment for posttransplantation Kaposi's sarcoma. Transplantation 2004; 77: 760.
18. Stallone G, Schena A, InfanteB, et al. Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 2005; 352:1317.
19. Miller G, Rigsby MO, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996; 334: 1292.
20. Qunibi W, Al-Furayh O, Almeshari K, et al. Serologic association of human herpesvirus eight with posttransplant Kaposi's sarcoma in Saudi Arabia. Transplantation 1998; 65: 583.
21. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005; 80(suppl 2): S272.
22. Penn I. Post-transplant malignancy. The role of immunosuppression. Drug Safety 2000; 23: 101.
23. Opelz G, Dohler B. Lymphomas after solid organ transplantation: A collaborative transplant study report. Am J Transplant 2004; 4: 222.
24. Caillard S, Lelong C, Pessione F, et al. Post-transplant lymphoprolif-erative disorders occurring after renal transplantation in adults: Report of 230 cases from the French registry. Am J Transplant 2006; 6: 2735.
25. Ho M, Jaffe R, Miller G, et al. The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation and its manifestations in children. Transplantation 1988; 45: 719.
26. Funch DP, Walker AM, Schneider G, et al. Ganciclovir and acyclovir reduce the riskof post-transplant lymphoproliferative disorder inrenal transplant recipients. Am J Transplant 2005; 5: 2894.
27. Everly MJ, Bloom RD, Tsai DE, et al. Posttransplant lymphoprolifera-tive disorder. Ann Pharmacother 2007; 41: 1850.
28. Buzzeo BD, Heisey DM, Messing EM. Bladder cancer in renal transplant recipients. Urology 1997; 50: 525.
29. EI-Bolkainy MN, Mokhtar NM, Ghoneim MA, et al. The impact of Schis-tosomiasis on the pathology of bladder carcinoma. Cancer 1981; 48: 2643.
30. Dantal J, Pohanka E. Malignancies in renal transplantation: An unmet medical need. Nephrol Dial Transplant 2007; 22(suppl 1): i4.
31. Morath C, Mueller M, Goldschmidt H, et al. Malignancy in renal transplantation. J Am Soc Nephrol 2004; 15: 1582.
32. Seif-Eldein IA, Hablas A, Elhamzawy H. Cancer in Egypt, Gharbiah. Tri-enniel report of 2000-2002, Gharbiah population-based cancer registry. Gharbiah Cancer Center, Egypt, 2007.